ليست عنوان مقالات لاتين Drosophila Gain-of-Function Mutant RTK Torso Triggers Ectopic Dpp and STAT Signaling Dry etching characteristics of GaN for blue/green light-emitting diode fabrication

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Drosophila Gain-of-Function Mutant RTK Torso Triggers Ectopic Dpp and STAT Signaling

2

Drosophila genome sequence, a model for the human

3

Drosophila Genome-wide Obesity Screen Reveals Hedgehog as a Determinant of Brown versus White Adipose Cell Fate

4

Drosophila gustatory receptors: from gene identification to functional expression

5

Drosophila immunity: paths and patterns

6

Drosophila immunity: two paths to NF-κB

7

Drosophila male courtship behavior is modulated by ecdysteroids

8

Drosophila males transfer antibacterial proteins from their accessory gland and ejaculatory duct to their mates

9

Drosophila melanogaster and D. simulans rescue strains produce fit offspring, despite divergent centromerespecific histone alleles

10

Drosophila melanogaster as a Model to Study Human Neurodegenerative Diseases

11

Drosophila melanogaster Laboratory Rearing for Wolbachia-Based Control Programs, a Component of Dengue Control

12

Drosophila melanogaster males increase the number of sperm in their ejaculate when perceiving rival males

13

Drosophila melanogaster Methoprene-tolerant (Met) gene homologs from three mosquito species: Members of PAS transcriptional factor family

14

Drosophila melanogaster syncytial nuclear divisions are patterned: time-lapse images, hypothesis and computational evidence

15

Drosophila microRNAs Are Sorted into Functionally Distinct Argonaute Complexes after Production by Dicer-1

16

Drosophila model increases understanding of fragile-X syndrome

17

Drosophila Myc Regulates Organ Size by Inducing Cell Competition

18

Drosophila neural progenitor polarity and asymmetric division

19

Drosophila Neuroblasts Sequentially Express Transcription Factors which Specify the Temporal Identity of Their Neuronal Progeny

20

Drosophila p53 Binds a Damage Response Element at the reaper Locus

21

Drosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53

22

Drosophila PAR-1 and 14-3-3 Inhibit Bazooka/PAR-3 to Establish Complementary Cortical Domains in Polarized Cells

23

Drosophila Proteasome Regulator REGγ: Transcriptional Activation by DNA Replication-related Factor DREF and Evidence for a Role in Cell Cycle Progression

24

Drosophila Replication and Repair Proteins: Proliferating Cell Nuclear Antigen (PCNA)

25

Drosophila Rho-Associated Kinase (Drok) Links Frizzled-Mediated Planar Cell Polarity Signaling to the Actin Cytoskeleton

26

Drosophila Rhomboid-1 Defines a Family of Putative Intramembrane Serine Proteases

27

Drosophila serpin 27A is a likely target for immune suppression of the blood cell-mediated melanotic encapsulation response

28

Drosophila Sir2 Is Required for Heterochromatic Silencing and by Euchromatic Hairy/E(Spl) bHLH Repressors in Segmentation and Sex Determination

29

Drosophila song as a species-specific mating signal and the behavioural importance of Kyriacou & Hall cycles in D. melanogaster song

30

Drosophila still flying high in cancer research

31

Drosophila Tsc1 Functions with Tsc2 to Antagonize Insulin Signaling in Regulating Cell Growth, Cell Proliferation, and Organ Size

32

Drosophila Tufted Is a Gain-of-Function Allele of the Proneural Gene amos

33

Drosophila wingless and Pair-Rule Transcripts Localize Apically by Dynein-Mediated Transport of RNA Particles

34

Drosophila Zinc Finger Protein CG9890 Is Colocalized with Chromatin Modifying and Remodeling Complexes on Gene Promoters and Involved in Transcription Regulation

35

Dross formation during remelting of aluminum 5182 remelt secondary ingot (RSI)

36

Dross formation during remelting of aluminum 5182 remelt secondary ingot (RSI)

37

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial

38

Drought 2002 in Colorado: An Unprecedented Drought or a Routine Drought?

39

Drought acclimation and lipid composition in Folsomia candida: implications for cold shock, heat shock and acute desiccation stress

40

Drought acclimation confers cold tolerance in the soil collembolan Folsomia candida

41

Drought adaptations in wild barley (Hordeum spontaneum) grown in Iran

42

Drought affects the fluxes of carbon to roots and soil in 13C pulse-labelled plants of wheat

43

Drought affects the fluxes of carbon to roots and soil in 13C pulse-labelled plants of wheat

44

Drought Allocations Using the Systems Impact Assessment Model: Klamath River

45

Drought alters respired δ13CO2 from autotrophic, but not heterotrophic soil respiration

46

Drought alters respired δ13CO2 from autotrophic, but not heterotrophic soil respiration

47

Drought analysis in the Lakes of Iran (Case study: Lake Urmia and Gavkhuni Swamp)

48

Drought and Aquatic Ecosystems: Effects and Responses, P. Sam Lake. Wiley-Blackwell, Oxford, Chichester, Hoboken (2011). xiv+381 pp., Price £55.00, Paperback, ISBN: 978-1-4051-8560-8 (also four electronic formats)

49

Drought and climatic change impact on streamflow in small watersheds Original Research Article

50

Drought and clipping effects on tiller demography andgrowth of two tussock grasses in Utah

51

Drought and declining reservoirs: Comparing media discourse in Arizona and New Mexico, 2002–2004

52

Drought and disputes, deluge and dearth: climatic variability and human response in colonial Oaxaca, Mexico

53

Drought and ecosystem carbon cycling

54

Drought and flood signals in subtropical estuaries recorded by stable isotope ratios in bivalve shells

55

Drought and grazing patch dynamics under different grazing management

56

Drought and malaria retreat in the Sahel, West Africa

57

Drought and Salinity Impacts on Bread Wheat in a Hydroponic Culture: A Physiological Comparison

58

Drought and salt tolerance enhancement of transgenic Arabidopsis by overexpression of the vacuolar pyrophosphatase 1 (EVP1) gene from Eucalyptus globulus

59

Drought and saving in West Africa: are livestock a buffer stock?

60

Drought and spring cooling induced recent decrease in vegetation growth in Inner Asia

61

Drought and the Impact of Natural Saline River on the Quality of Surface Water Resources In Karoon River(IRAN)

62

Drought changes the dynamics of trace element accumulation in a Mediterranean Quercus ilex forest

63

Drought class transition analysis through Markov and Loglinear models, an approach to early warning

64

Drought constraints on transpiration and canopy conductance in mature aspen and jack pine stands

65

Drought decreases soil enzyme activity in a Mediterranean Quercus ilex L. forest

66

Drought decreases soil enzyme activity in a Mediterranean Quercus ilex L. forest

67

Drought disturbance from climate change: response of United States forests

68

Drought duration and frequency in the U.S. Corn Belt during the last millennium (AD 992–2004)

69

Drought early warning system in reservoir operation: Theory and practice

70

Drought effects on elongation kinetics and sugar deposition in the elongation zone of durum wheat (Triticum durum Desf.) leaves

71

Drought effects on the early development stages of Panicum virgatum L.: Cultivar differences

72

Drought effects on water relations in beech: The contribution of exchangeable water reservoirs

73

DROUGHT EFFECTS ON YIELD TRAITS OF SOME SUNFLOWER INBRED LINES

74

Drought evolution at various time scales in the lowland regions and their impact on vegetable crops in the Czech Republic

75

Drought experiments within the Solling roof project

76

Drought Flow from Hillslope

77

Drought Flow from Hillslope

78

Drought forecasting based on the remote sensing data using ARIMA models

79

Drought forecasting using feed-forward recursive neural network

80

Drought forecasting using feed-forward recursive neural network

81

Drought forecasting using the Standardized Precipitation Index

82

Drought frequency analysis using cluster analysis and bivariate probability distribution

83

Drought identification and characterization in Jordan

84

Drought impacts on the water quality of freshwater systems; review and integration

85

Drought in groundwater—drought distribution and performance indicators

86

Drought induced pulses of image from a Canadian shield wetland: use of δ34S and δ18O in image to determine sources of sulfur

87

Drought is a major yield loss factor for rainfed East African highland banana

88

Drought mitigation using operative indicators in complex water systems

89

Drought modeling – A review

90

Drought Monitoring and Corn Yield Estimation in Southern Africa from AVHRR Data

91

Drought Monitoring and Prediction using K-Nearest Neighbor Algorithm

92

Drought Monitoring Based on the SPI and RDI Indices under Climate Change Scenarios (Case Study: Semi-Arid Areas of West Golestan Province)

93

Drought monitoring in Iran using the perpendicular drought indices

94

Drought Monitoring in Southern Coasts of Iran

95

Drought monitoring using a Soil Wetness Deficit Index (SWDI) derived from MODIS satellite data

96

Drought Monitoring Using Climatic Indices and Geostatistic Technique (Case Study: Hossein Abad Plain, Sarbisheh, Iran)

97

Drought Monitoring Using MODIS Land Surface Temperature and Normalized Difference Vegetation Index Products in Semi-Arid Areas of Iran

98

Drought Monitoring Using Vegetation Indices and MODIS Data (Case Study: Isfahan Province, Iran)

99

Drought Occurrence Pattern in Tigray Region, Northern Ethiopia

100

Drought Occurrence Probabilities and Risks of Dependent Hydrologic Processes

101

Drought planning and water allocation: an assessment of local capacity in Minnesota

102

Drought prediction using the Along Track Scanning Radiometer (ATSR2) on board ERS2 satellite Original Research Article

103

Drought probabilities and return period for annual streamflows series

104

Drought resistance of 2-year-old saplings of Mediterranean forest trees in the field: relations between water relations, hydraulics and productivity

105

Drought response of two bedding plants

106

Drought responses of Arrhenatherum elatius grown in plant assemblages of varying species richness

107

Drought Risk Assessment In Iraq Using Remote Sensing And GIS Techniques

108

Drought Risk Assessment in Western Inner-Mongolia

109

Drought Risk Assessment: A Case Study in Punjab, Pakistan

110

Drought risk management in agricultural sector with an emphasis on the socioeconomic dimension under Fuzzy Logic in the Sistan region

111

Drought Risk Vulnerability Parameters among Wheat

112

Drought Scenario Analysis Using RiverWare: A Case Study in Urumqi River Basin, China

113

Drought signals in tree-ring stable oxygen isotope series of Qilian juniper from the arid northeastern Tibetan Plateau

114

Drought stress and fluctuating asymmetry in Quercus undulata leaves: confounding effects of absolute and relative amounts of stress?

115

Drought Stress Effect on germination and Seedling Growth Indices in 5 Sugar Beet Genotypes

116

Drought stress effect on some phonological traits of advanced lines of bread wheat

117

Drought stress has contrasting effects on antioxidant enzymes activity and phenylpropanoid biosynthesis in Fraxinus ornus leaves: An excess light stress affair?

118

Drought Stress Impact on Some Biochemical and Physiological Traits of 4 Groundcovers (Lolium perenne, Potentilla spp, Trifolium repens and Frankinia spp) with Potential Landscape Usage

119

Drought Stress in Iranian Endemic Savory (Satureja rechingeri): In vivo and In vitro Studies

120

DROUGHT STRESS INCREASES THE EXPRESSION OF WHEAT LEAF RIBULOSE- 1, 5- BISPHOSPHATE CARBOXYLASE/OXYENASE PROTEIN

121

Drought stress tolerance based on selection indices of resistant crops variety

122

Drought stress tolerance of barley (Hordeum vulgare L.) affected by priming with PEG

123

Drought stress, plant water status, and floral trait expression in fireweed, Epilobium angustifolium (Onagraceae)

124

Drought Stress: A Review

125

Drought Stress-Induced Changes at Physiological and Biochemical Levels in Some Common Vetch (Vicia sativa L.) Genotypes

126

Drought stress-induced compositional changes in tolerant transgenic rice and its wild type

127

Drought stress-induced upregulation of components involved in ferredoxin-dependent cyclic electron transfer

128

Drought threatened semi-arid ecosystems in the Inner Asia

129

Drought tolerance associated with vertical stratification of two co-occurring epiphytic bromeliads in a tropical dry forest

130

Drought Tolerance in Cultivated and Wild Barley Genotypes: The Role of Root System Characteristics

131

Drought Tolerance is Associated with Rooting Depth and Stomatal Control of Water Use in Clones of Coffea canephora

132

Drought Tolerance of Selected Eragrostis Species Correlates with Leaf Tensile Properties

133

Drought Tolerance Screening in Thirty Common Wheat (Triticum aestivum L.) Genotypes

134

Drought tolerance through overexpression of monoubiquitin in transgenic tobacco

135

Drought tolerance through over-expression of the expansin gene TaEXPB23 in transgenic tobacco

136

Drought tolerance, phosphorus efficiency and yield characters of upland rice lines

137

DROUGHT TOLERANT WHEAT CULTIVAR (RAJ) FOR RAINFED AREAS OF KPK, PAKISTAN

138

Drought Utilization Management of Surface and Ground Water (Case study: Qaryat-Al-Arab Watershed)

139

Drought variability and its climatic implications

140

Drought variation trends in different subregions of the Chinese Loess Plateau over the past four decades

141

Drought vulnerability assessment: The case of wheat farmers in Western Iran

142

Drought vulnerability drives land-use and land cover changes in the Rift Valley dry lands of Ethiopia

143

Drought year changes in streambank profiles on incised streams in the Sierra Nevada Mountains

144

Drought, Abscisic Acid and Transpiration Rate Effects on the Regulation of PIP Aquaporin Gene Expression and Abundance in Phaseolus vulgaris Plants

145

Drought, but not salinity, determines the apparent effectiveness of halophytes colonized by arbuscular mycorrhizal fungi

146

Drought, floods and water quality: Drivers of a severe hypoxic blackwater event in a major river system (the southern Murray–Darling Basin, Australia)

147

Drought-adaptive mechanisms involved in the escape/tolerance strategies of Arabidopsis Landsberg erecta and Columbia ecotypes and their F1 reciprocal progeny

148

Drought-induced changes and recovery of photosynthesis in two bean cultivars (Phaseolus vulgaris L.)

149

Drought-induced changes in acid phosphatase activities in wheat in relationship with phosphorus

150

Drought-induced chilling tolerance in cucumber involves Drought-induced chilling tolerance in cucumber involves

151

Drought-induced reduction in uptake of recently photosynthesized carbon by springtails and mites in alpine grassland

152

Drought-induced reduction in uptake of recently photosynthesized carbon by springtails and mites in alpine grassland

153

Drought-induced responses of photosynthesis and antioxidant metabolism in higher plants Review Article

154

Drought-induced variations of water relations parameters in Olea europaea

155

Drought-induced weakening of growth–temperature associations in high-elevation Iberian pines

156

Drought-resistant physiological characteristics of four shrub species in arid valley of Minjiang River, China

157

Drought-responsive mechanisms in rice genotypes with contrasting drought tolerance during reproductive stage

158

Droughts and famines: The underlying factors and the causal links among agro-pastoral households in semi-arid Makueni district, Kenya

159

DROUGHTS AND THEIR IMPACT ON THE ALBANIAN TERRITORY

160

Droughts as random events in the Maya lowlands

161

Drought-sensitivity ranking of deciduous tree species based on thermal imaging of forest canopies

162

Drove roads: Keystone structures that promote ant diversity in Mediterranean forest landscapes

163

Drowned coralline algal dominated deposits off Lanai, Hawaii; carbonate accretion and vertical tectonics over the last 30 ka

164

Drowned shelf-edge deltas, barrier islands and related features along the outer continental shelf north of the head of De Soto Canyon, NE Gulf of Mexico

165

Drowning by numbers and itʹs

166

Drowning discontinuities and stratigraphic correlation in platform carbonates. The late Barremian–early Aptian record of southeast France

167

Drowning in information, but thirsty for knowledge

168

Drowning of a nearshore peat-forming environment, Atane Formation (Cretaceous) at Asuk, West Greenland: sedimentology, organic petrography and geochemistry

169

Drowning out the protection racket: partner manipulation or drought can strengthen ant–plant mutualism

170

Drowning out the protection racket: partner manipulation or drought can strengthen ant–plant mutualism

171

Drowning-out crystallisation of sodium sulphate using aqueous two-phase systems

172

Drowning-out crystallization of l-proline: Effect of anti-solvent composition and processing parameters on crystal size and shape

173

Drowsiness Analysis Using Common Spatial Pattern and Extreme Learning Machine Based on Electroencephalogram Signal

174

Drowsiness Detection – A Visual System for Driver Support

175

Drs. Landon and Kahn respond:

176

dRTP and dPTP a complementary nucleotide couple for the Sequence Saturation Mutagenesis (SeSaM) method

177

Drucker–Prager–Cap creep modelling of pebble beds in fusion blankets

178

Drudeʹs model calculation rule on electrical transport in Sb-doped SnO2 thin films, deposited via sol–gel Original Research Article

179

Druen complement component C3a and C5a promote choroidal neovacularization

180

Drug Use Evaluation of Three Widely Prescribed Antibiotics in a

181

Drug absorption and release properties of crosslinked hydrogels based on diepoxy-terminated poly(ethylene glycol)s and aliphatic polyamines — a study on the effect of the gel molecular structure

182

Drug abuse among nurses: A neglected challenge

183

Drug Abuse among University Students of Rafsanjan, Iran

184

Drug abuse and aggression between intimate partners: A meta-analytic review

185

Drug abuse and bipolar disorder: comorbidity or misdiagnosis?

186

Drug abuse in older US adults worries experts

187

Drug Abuse in Prishtina Region

188

Drug Abuse Pattern and High Risk Behaviors among Addicts in Shahroud County of Semnan Province, Northeast Iran in 2009

189

Drug Abuse Research Trend Investigation with Text Mining

190

Drug abuse toll uncovered in Kenya

191

Drug abuse, HIV/AIDS and stigmatisation in a Dai community in Yunnan, China

192

Drug abuse: A significant variable in schizophrenia research

193

Drug Action at the 5-HT(1A) Receptor in Vivo: Autoreceptor and Postsynaptic Receptor Occupancy Examined with PET and [carbon:yl-11C]WAY-100635

194

Drug Action of Ritodrine on the Sarcoplasmic-Reticulum Ca2+-ATPase from Skeletal Muscle

195

Drug actions in preeclampsia: Aspirin, but not magnesium chloride or dihydralazine, differentially inhibits cultured human trophoblast release of thromboxane and prostacyclin without affecting angiotensin II, endothelin-1, or leukotriene B4 secretion

196

DRUG ADDICTION AND HEPATITIS B AND C IN PAKISTAN

197

Drug addiction and HIV infection on rise in Tajikistan

198

Drug addiction and the economic rationalization of gun control

199

Drug addiction and the economic rationalization of gun control

200

Drug Addiction and Vitamin D Supplementation: How to Address a Health Concern in Methadone Treatment?

201

Drug addiction as drive satisfaction ("antidrive") dysfunction

202

Drug Addiction as Risk for Suicide Attempts

203

Drug addiction in Gaza and the illicit trafficking of tramadol

204

Drug addiction: the neurobiology of disrupted self-control

205

Drug administration to poultry

206

Drug adverse events and drop-out risk: A clinical case

207

Drug advertisements and prescribing

208

Drug advertisements and prescribing

209

Drug advertisements in less-developed countries

210

Drug advertisements in medical journals

211

Drug advertisements that go straight to the hippocampus

212

Drug advertising in medical journals

213

Drug advertising in medical journals

214

Drug advertising in medical journals

215

Drug advertising in medical journals

216

Drug advertising in medical journals

217

Drug advertising in medical journals

218

Drug affinity to immobilized target bio-polymers by high-performance liquid chromatography and capillary electrophoresis

219

Drug allergic reactions and distress vulnerability

220

Drug allergies among patients with borderline personality symptomatology

221

222

Drug allergy transmitted by passionate kissing

223

Drug and alcohol abuse: A clinical guide to diagnosis and treatment (4th ed.) : Marc A. Schuckit. New York: Plenum Press, 1995. 371 pp. (xviii), $34.50

224

Drug and Alcohol Education for Consumer Workers and Caregivers: A Pilot Project Assessing Attitudes Toward Persons With Mental Illness and Problematic Substance Use

225

Drug and alcohol use among drivers admitted to a Level-1 trauma center

226

Drug and Alcohol Use in Emergency Medicine Residency: An Impaired Residentʹs Perspective

227

Drug and alcohol use in Spain: consumption habits, attitudes and opinions

228

Drug and cell encapsulation: Alternative delivery options for the treatment of malignant brain tumors

229

Drug and chemical metabolites in clinical toxicology investigations: The importance of ethylene glycol, methanol and cannabinoid metabolite analyses

230

Drug and DNA delivery to mitochondria

231

Drug and DNA delivery to mitochondria

232

Drug and ECT treatment of depression in the elderly, 1996–2001: a literature review

233

Drug and gene delivery to mucosal tissues: the mucus barrier

234

Drug and herbal medicine-induced nephrotoxicity in children; review of the mechanisms

235

Drug Attitude Inventory in Patients with Bipolar Disorder: Psychometric Properties

236

Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor

237

DRUG BIT CUTTING TRACE IMAGE COLOURS AND CUTTING FORCE FLUCTUATION RELATION

238

Drug bulletins: independent information for global use

239

Drug Calculation Cards and Medication Errors in the Neonatal Intensive Care Units

240

Drug calculation skills — Are we running scared?

241

Drug Calculations for Nurses: Robert Lapham, Heather Agar, Arnold, 1995, 0-340604-79-4, 250 pages, Price £5.99

242

Drug choices in the treatment of atrial fibrillation

243

Drug classification systems: Applications and characteristics

244

Drug Clearance and Arterial Uptake After Local Perivascular Delivery to the Rat Carotid Artery

245

Drug combinations best in acute asthma attacks

246

Drug combinations for HD tested in Drosophila

247

Drug combinations for malaria: time to ACT?

248

Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination

249

Drug companies can broadcast across Europe

250

Drug companies caught again for fixing worldwide vitamin prices

251

Drug company sued over research trial in Nigeria

252

Drug company trials come under increasing scrutiny

253

Drug comparison and categorizing regarded with human serum albumin

254

Drug complications poorly recorded in medical charts

255

Drug courts for DWI offenders? The effectiveness of two hybrid drug courts on DWI offenders

256

Drug courts: A bridge between criminal justice and health services

257

Drug Craving Terminology among Opiate Dependents;

258

Drug Cravings and Its Relationship With Family Communication Patterns and Resiliency Through the Mediatory Role of Difficulty in Cognitive Emotion Regulation

259

Drug crops threaten Colombian birds

260

261

Drug delivery and tissue engineering applications of biocompatible pectin–chitin/nano CaCO3 composite scaffolds

262

Drug delivery applications of supercritical fluid technology

263

Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: Illustration with the case of taxane therapeutics

264

Drug delivery devices based on macroporous silica spheres

265

Drug Delivery for Brains and Central Nervous System

266

Drug delivery for in vitro fertilization: Rationale, current strategies and challenges

267

Drug delivery from gold and titanium surfaces using self-assembled monolayers

268

Drug delivery from hydrophobic-modified mesoporous silicas: Control via modification level and site-selective modification

269

Drug delivery in degenerative joint disease

270

Drug delivery in degenerative joint disease: Where we are and where to go?

271

Drug delivery investigations of quaternised poly(propylene imine) dendrimer using nimesulide as a model drug

272

Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors

273

Drug Delivery Platforms for Vaginal Infection: Biological Barriers, Microbe-Associated Infections, and Delivery

274

Drug delivery property, bactericidal property and cytocompatibility of magnetic mesoporous bioactive glass

275

Drug delivery strategies for photodynamic antimicrobial chemotherapy: From benchtop to clinical practice

276

Drug delivery strategies in the therapy of inflammatory bowel disease

277

Drug delivery strategies to treat age-related macular degeneration

278

Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities

279

Drug delivery system based on cyclodextrin-naproxen inclusion complex incorporated in electrospun polycaprolactone nanofibers

280

Drug delivery systems : Vascant V. Ranade and Mannfred A. Hollinger CRC Press, Boca Raton, Florida, 1995, 364 pp. Dr Lisa Brannon-Peppas

281

Drug delivery systems using sandwich configurations of electrospun poly(lactic acid) nanofiber membranes and ibuprofen

282

Drug delivery systems: polymers and drugs monitored by capillary electromigration methods

283

Drug delivery therapies I: General trends and its importance on bone tissue engineering applications

284

Drug delivery therapies II.: Strategies for delivering bone regenerating factors

285

Drug Delivery through Nose: A Noninvasive Technique for Brain Targeting

286

Drug delivery to mitochondria: the key to mitochondrial medicine

287

Drug delivery to mitochondria: the key to mitochondrial medicine

288

Drug delivery to peroxisomes: Employing unique trafficking mechanisms to target protein therapeutics

289

Drug delivery to solid tumors by elastin-like polypeptides

290

Drug delivery to the brain in Alzheimerʹs disease: Consideration of the blood–brain barrier

291

Drug delivery to the brain-just a sniff away

292

Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?

293

Drug delivery to the posterior segments of the eye

294

Drug delivery vehicles on a nano-engineering perspective

295

Drug Demand Function for Iranian Urban Households Based on Householdsʹ Budget

296

Drug Dependency and Womenʹs Health

297

Drug dependent parents: Childcare responsibilities, involvement with treatment services, and treatment outcomes

298

Drug deregulation in Japan likely by 1998

299

Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase

300

Drug design and synthesis of ε opioid receptor agonist: 17-(cyclopropylmethyl)-4,5α-epoxy-3,6β-dihydroxy-6,14-endoethenomorphinan-7α-(N-methyl-N-phenethyl)carboxamide (TAN-821) inducing antinociception mediated by putative ε opioid receptor Original Resea

301

Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease Original Research Article

302

Drug design, synthesis, and evaluation of a non-sugar-based selectin antagonist

303

Drug design; HIV; Organosilane; Protease inhibitor; Silanediol

304

Drug detection based on the conformational changes of calmodulin and the fluorescence of its enhanced green fluorescent protein fusion partner Original Research Article

305

Drug detection by tandem mass spectrometry on the basis of adduct formation

306

Drug development and clinical research in the UK

307

Drug development for neglected diseases

308

Drug development for neglected diseases: a deficient market and a public-health policy failure

309

Drug development for tuberculosis: the missing ingredient

310

Drug development output: what proportion for tropical diseases?

311

Drug diffusion from disperse systems with a hydrophobically modified polysaccharide: Enhancer® vs Franz cells

312

Drug diffusion in hydrophobically modified N,N-dimethylacrylamide hydrogels

313

Drug Diffusion Inside a Non-Degradable Hydrogel Microneedle

314

DRUG DISCONTINUATION IN EPILEPTIC CHILDREN: PREDICTIVE VALUE OF THE EEG

315

Drug Discovery Acceleration Using Digital Microfluidic Biochip Architecture and Computer-aided-design Flow

316

Drug discovery and chemokine receptor antagonists: eppur si muove!

317

Drug Discovery and Delivery in the 21st Century

318

Drug Discovery and Evaluation

319

Drug discovery and sea hares: bigger is better

320

Drug Discovery in the Clouds

321

Drug discovery in the new millennium: the pivotal role of biotechnology

322

Drug discovery in the wake of genomics

323

Drug discovery of the future: the implications of the human genome project

324

Drug discovery through stem cell-based organoid models

325

Drug dispensing systems in Gaza hospitals: a comparative study

326

Drug disposition in obesity and protein-energy malnutrition

327

Drug distribution within poly(ɛ-caprolactone) microspheres and in vitro release

328

Drug dosing errors in simulated paediatric emergencies – Comprehensive dosing guides outperform length-based tapes with precalculated drug doses

329

Drug efficacy of praziquantel and albendazole in school children in Mwea Division, Central Province, Kenya

330

Drug efflux transporters in the CNS

331

Drug elimination in chronic liver diseases

332

Drug eluting stent

333

Drug ELuting Stent Complications

334

Drug eluting stent implantation for the treatment of symptomatic myocardial bridging is associated with favorable peri-procedural results and short-term outcomes

335

Drug Eluting Stent Restenosis

336

Drug eluting stents

337

Drug Eluting Stents Comparisons

338

Drug Eluting Stents I

339

Drug Eluting Stents II

340

Drug Eluting Stents in Diabetic Patients

341

Drug eluting stents may not be the answer for myocardial bridges

342

Drug eluting stents: Comparative results

343

Drug eluting stents: Current status and new developments

344

Drug eluting stents: In stent restenosis

345

Drug eluting stents: Long term results

346

Drug eradicates Chagasʹ parasite in mice

347

Drug evaluations using a novel microphysiometer based on cell-based biosensors

348

Drug excretion in breast milk: mechanisms, models and drug delivery implications for the infant

349

Drug excretion into breast milk—Overview

350

Drug exposed infants in the social welfare system and Juvenile Court

351

Drug firm buys up chain of US cancer clinics

352

Drug firm compensates patients for suspected hepatitis B vaccine failure

353

Drug firm support of American Medical Association ethics effort draws fire

354

Drug firm withdraws statin from the market

355

Drug firms lose patent rights lawsuit against South Africaʹs government

356

Drug firmsʹ representatives express concern over WHOʹs AIDS drug list

357

Drug firms take South Africaʹs government to court

358

Drug firms under fire over anti-competition in USA

359

Drug for impotence breaks prescription records

360

Drug Guru: A computer software program for drug design using medicinal chemistry rules Original Research Article

361

drug hypersensitivity reactions in hospital-admitted children: a single center study in southern iran

362

Drug Hypersensitivity Reactions in Hospital-Admitted Children: A Single Center Study in Southern Iran

363

Drug identification performance on the basis of observable signs and symptoms

364

Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants

365

Drug immunosuppression therapy for adult heart transplantation. Part 2: clinical applications and results

366

Drug impurity profiling: Method optimization on dissimilar chromatographic systems: Part I: pH optimization of the aqueous phase Original Research Article

367

DRUG INDUCED (CALCIUM CHANNEL BLOCKERS) GINGIVAL HYPERPLASIA

368

Drug Induced Autoimmune Hepatitis by Amoxicillin- Clavulanate

369

Drug induced blistering and the plastic surgeon: a case of amitriptyline induced skin necrosis

370

Drug Induced Ectropion: a Systematic Review

371

Drug Induced Gingival Overgrowth and Its Management

372

Drug induced hepatitis among Iranian patients suffering from tuberculosis

373

Drug Induced Sialorrhea and Microfluidic-Chip-Electrophoretic Analysis of Engorged Adult Female Tick Saliva of Haemaphysalis longicornis (Acari: Ixodidae)

374

Drug Induced Sleep Endoscopy in Obstructive Sleep Apnea

375

Drug industry lobbies against European research-data directive

376

Drug Information Resources at Private Community Pharmacies in Kuwait

377

Drug Injecting and HIV Infection: Global Dimensions and Local Responses; Edited by Gerry Stimson, Don C. Des Jarlais and Andrew Ball. UCL Press Ltd, London, 1998. 294 pp, £14.95 (paper).

378

Drug injection and associated factors among the elderly living with HIV/AIDS in Tehran, Iran

379

Drug injection cessation among HIV-infected injecting drug users

380

Drug interaction between rifampicin and sirolimus in transplant patients

381

Drug Interaction of Glycyrrhiza glabra L. with Chemical Drugs: A mini Review study

382

Drug interaction of St Johnʹs wort with ciclosporin

383

Drug Interactions Among Hospitalized Patients in Intensive Care Units and Infectious Ward, Hamadan, Iran

384

Drug interactions and anti-infective therapies

385

Drug Interactions between Psychoactive Agents and Antiepileptic Agents

386

Drug Interactions Casebook: The Cytochrome P450 System and Beyond, 2nd ed.: By Neil B. Sandson. Washington, DC, American Psychiatric Press, 2003 ($35.50, paperback ed.), 334 pp

387

Drug interactions in cancer patients: A hidden risk?

388

Drug Interactions in Iranian Veterans With Chronic Spinal Cord Injury - A Descriptive Study

389

Drug Interactions of Green Tea

390

Drug Interactions of Medicinal Plants with Chemical Antidiabetic Drugs

391

Drug Interactions of Metformin Involving Drug Transporter Proteins

392

Drug Interactions of Psychiatric and COVID-19 Medications

393

Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding

394

Drug interactions with potential rubber closure extractables: Identification of thiol–disulfide exchange reaction products of captopril and thiurams

395

Drug interactions with the taxanes: clinical implications

396

Drug interactions with zileuton

397

Drug interactions with zileuton

398

Drug interactions—fact or fiction?

399

Drug intervention trials in sepsis

400

Drug intervention trials in sepsis: divergent results

401

Drug kinetics and drug resistance in optimal chemotherapy

402

Drug Literacy in Iran: the Experience of Using “The Single Item Health Literacy Screening (SILS) Tool”

403

Drug loaded poly[Lac(Glc-Leu)] microparticles: Formulation and release characteristics

404

Drug loaded thermoresponsive and cytocompatible chitosan based hydrogel as a potential wound dressing

405

Drug loading onto ion-exchange microspheres: Modeling study and experimental verification

406

Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes Original Research Article

407

Drug Management in Crisis and Disaster in Selected Countries and Iran

408

DRUG MANAGEMENT REVIEWS IN DISTRICT DRUG MANAGEMENT UNIT AND GENERAL HOSPITAL

409

Drug may avoid need for parathyroidectomy

410

Drug Mediated S-glutathionylation of PDI leads to alterations in secondary structure, inhibition of isomerase activity, and triggers ER-stress induced apoptosis

411

Drug metabolism and drug interactions in the elderly

412

Drug metabolism enzymes in a steatotic model of rat treated with a high fat diet and a low dose of streptozotocin

413

Drug name confusion: evaluating the effectiveness of capital (“Tall Man”) letters using eye movement data

414

Drug nanocarrier agents based on starch-g-amino acids

415

Drug Nano-Particles Formation by Supercritical Rapid Expansion Method; Operational Condition Effects Investigation

416

Drug partition chromatography on immobilized porcine intestinal brush border membranes

417

Drug Patents 2001: A Review of Pharmaceutical Patenting, 1995–2001

418

Drug permeation modeling through the thermo-sensitive membranes of poly(N-isopropylacrylamide) brushes grafted onto micro-porous films

419

Drug permeation through temperature-sensitive membranes prepared from poly(vinylidene fluoride) with grafted poly(N-isopropylacrylamide) chains

420

Drug policy in China: pharmaceutical distribution in rural areas

421

Drug policy: should the law take a back seat?

422

Drug prescribing practices of general practitioners and paediatricians for childhood diarrhoea in Karachi, Pakistan

423

Drug prescription habits in public and private health facilities in 2 provinces in South Africa

424

Drug Prescription Pattern in a Nigerian Tertiary Hospital

425

Drug prescriptions after acute myocardial infarction: Dosage, compliance, and persistence

426

Drug prescriptions and referral to cardiac rehabilitation after acute coronary events: comparison between men and women in the French PREVENIR Survey

427

Drug prevents SIV infection

428

Drug pricing policies in one of the largest drug manufacturing nations in the world: Are affordability and access a cause for concern?( Editorial Jan-Mar 2015 / Vol 4 / Issue 1)

429

Drug problem recognition among african american drug-using arrestees

430

Drug Properties, Chemical Reactivity and Docking Binding Energy of Cinnamon with Estrogen, Testosterone, Progesterone as Potential Drug: Theoretical Investigation

431

Drug quality, a contributor to drug resistance?

432

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Cause Interstitial Nephritis: a case Report and Review of Literatures

433

Drug Rash With Eosinophilia and Systemic Symptoms Syndrome in Infancy: A Report of Two Rare Cases

434

Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification

435

Drug Reaction with Eosinophilia and Systemic Symptom in a Patient with Pneumonia and Hyperthyroidism

436

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Presenting with Primary Diagnosis of Hepatocellular Carcinoma

437

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Myocarditis: A Case Report and Literature Review on Fatal Complications of Reactivated Viral Infections

438

Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report

439

Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report

440

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin

441

Drug Receptor Identification from Multiple Tissues Using Cellular-Derived mRNA Display Libraries Original Research Article

442

Drug Recognition and Stabilisation of the Parallel-stranded DNA Quadruplex d(TTAGGGT)4 Containing the Human Telomeric Repeat

443

Drug referendum backs Swiss government

444

Drug reimportation: sitting in the middle

445

Drug related deaths in Tehran, Iran: Toxicological, Death and Crime Scene investigations

446

Drug related deaths—causes and numbers

447

Drug Related Hospital Admissions; A Systematic Review of the Recent Literatures

448

Drug release behavior of beads and microgranules of chitosan

449

Drug release behavior of chitosan–montmorillonite nanocomposite hydrogels following electrostimulation

450

Drug Release Characteristics and Tissue Distribution of Rifapentine Polylactic Acid Sustained-Release Microspheres in Rabbits after Paravertebral Implantation

451

Drug release characteristics of phase separation pHEMA sponge materials

452

Drug release from a N-vinylpyrrolidinone/acrylic acid lubricious hydrophilic coating

453

Drug release from a porous ion-exchange membrane in vitro

454

Drug release from a two-layer stent coating considering the viscoelastic property of the arterial wall: A mathematical and numerical study

455

Drug release from calcium and zinc pectinate beads: Impact of dissolution medium composition

456

Drug release from chitosan–alginate complex beads reinforced by a naturally occurring cross-linking agent

457

Drug release from ion-exchange microspheres: Mathematical modeling and experimental verification

458

Drug release from layered double hydroxides and from their polylactic acid (PLA) nanocomposites

459

Drug release from starch-acetate microparticles and films with and without incorporated α-amylase

460

Drug release from α,β-poly(N-2-hydroxyethyl)- -aspartamide-based microparticles

461

Drug release kinetics and biological properties of a novel local drugcarrier system

462

Drug release kinetics from monolayer films of glucose-sensitive microgel

463

Drug release mechanisms of chemically cross-linked albumin microparticles: Effect of the matrix erosion

464

Drug release rate and kinetic investigation of composite polymeric nanofibers

465

Drug Release Studies from Caesalpinia pulcherrima Seed Polysaccharide

466

Drug Release Studies of Naproxen Agglomerates Produced by the Antisolvent Approach in the Presence of Hydroxypropyl Cellulose

467

Drug release through liposome pores

468

Drug Repositioning and Pharmacophore Identification in the Discovery of Hookworm MIF Inhibitors Original Research Article

469

Drug Repositioning: A Review

470

Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches

471

Drug Repurposing Is a New Opportunity for Developing Drugsagainst Neuropsychiatric Disorders

472

Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review

473

Drug resistance among acid-fast bacilli

474

Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city

475

Drug resistance and apoptosis-inducing strategies in cancer therapy

476

Drug resistance and influenza pandemics

477

Drug resistance and influenza pandemics

478

Drug resistance and influenza pandemics

479

Drug resistance and influenza pandemics

480

Drug Resistance and Serotyping of Uropathogenic Escherichia coli Among Patients With Urinary Tract Infection in Rasht, Iran

481

Drug resistance and Susceptibility of Mycobacterium tuberculosis identified at University Kebangsaan Malaysia Medical Centre

482

Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review

483

Drug resistance and virulence-associated genes screening in Salmonella enterica isolated from Caspian pony, Iran

484

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

485

Drug resistance gene transfer: Stem cell protection and therapeutic efficacy

486

Drug resistance in cancer, J.H. Goldie, A.J. Goldman. Cambridge University Press, Cambridge (1998)

487

Drug resistance in epilepsy: not futile, but complex?

488

Drug Resistance in Equine Parasites: An Emerging Global Problem

489

Drug resistance in isolated bacteria from milk of sbeep and goats witb subclinical mastitis in Sbabrekord district

490

Drug resistance in malaria: Its population biology and implications for control

491

Drug Resistance in the Clinical Management of HIV – A Special Focus on the Adherence Issues

492

Drug resistance in tuberculosis—a reinfection model

493

Drug resistance models for malaria

494

Drug Resistance of Acinetobacter in Selected Hospitals

495

Drug resistance of isolated strains of Pseudomonas Aeruginosa from burn wound infections to selected antibiotics and disinfectants

496

DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS

497

Drug Resistance of Mycobacterium tuberculosis Complex among Newly Diagnosed Tuberculosis Cases in Burkina Faso

498

Drug Resistance of Pseudomonas aeruginosa and Enterobacter cloacae Isolated from ICU, Babol, Northern Iran

499

DRUG RESISTANCE PATTERN AMONG AFB SMEAR POSITIVE RETREATMENT COMPLETED CASES

500

Drug resistance pattern and associated risk factors of tuberculosis patients in the central province of Iran

501

Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis

502

Drug Resistance Pattern of Pseudomonas aeruginosa Isolates Carrying MexAB-OprM Efflux Pump’s Associated Genes in Companion Birds with Respiratory Infection

503

Drug resistance pattern of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients at Isfahan AL Zahra hospital, Iran (2009-2010)

504

Drug Resistance Patterns in HIV Patients with Virologic Failure in Iran

505

Drug resistance patterns in pulmonary tuberculosis

506

Drug resistance profile and subtyping of HIV-1 RT gene in Iranian patients under treatment

507

Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells

508

Drug Resistance versus Spiritual Resistance: A Comparative Analysis from the Perspective of Spiritual Health

509

Drug resistance, plasmids, biotypes and susceptibility to bacteriophages of Salmonella isolated from poultry in Canada

510

Drug Resistance: A Periplasmic Ménage à Trois

511

Drug resistance–virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission

512

Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy

513

Drug resistant Plasmodium falciparum in an area of seasonal transmission

514

Drug resistant tuberculosis in Africa: Current status, gaps and opportunities

515

Drug Resistant Tuberculosis: Gold, Glitter and Hope

516

Drug risk assessment with determining the number of sub-populations under finite mixture normal models

517

Drug Safety Crises Management in Pharmacovigilance

518

Drug Screening versus History in detection of substance use in ED Psychiatric Patients

519

520

Drug sensitivity of trypanosome populations from cattle in a peri-urban dairy production system in Uganda

521

Drug sensitivity patterns of bacterial isolates from septic post-operative wounds in a regional referral hospital in Uganda

522

Drug shows potential for treatment of Huntingtonʹs disease

523

Drug shows promise for treatment of Alzheimerʹs disease

524

Drug solubility: how to measure it, how to improve it

525

Drug Stroop performance: Relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample

526

Drug subsidy could help Tanzania tackle malaria

527

Drug Supply Chain Management and Implementation of Health Reform Plan in Teaching Hospital Pharmacies of Ahvaz, Iran

528

DRUG SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE STRAINS ISOLATED IN TEHRAN, IRAN

529

Drug Switching, a Creative Approach to Leukemia Therapy

530

Drug target inference through pathway analysis of genomics data

531

Drug targeting of airway surface liquid: A pharmacological MRI approach

532

Drug targeting to choroidal neovascularization

533

Drug targeting to hypoxic tissue using self-inactivating bioreductive delivery systems

534

Drug targeting to the kidney

535

Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells

536

Drug testing litigation: Trends and outcomes

537

Drug testing sworn law enforcement officers: One agencyʹs experience

538

Drug Therapeutic Failures as a Cause of Admission to an Intensive Care Unit at a University Hospital

539

540

541

Drug therapy and microvolt T-wave alternans testing

542

Drug therapy and microvolt T-wave alternans testing

543

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy

544

Drug therapy for coronary heart disease: the Sheffield table

545

Drug therapy for coronary heart disease: the Sheffield table

546

Drug therapy for coronary heart disease: the Sheffield table

547

Drug therapy for coronary heart disease: the Sheffield table

548

Drug therapy for coronary heart disease: the Sheffield table

549

Drug therapy for coronary heart disease: the Sheffield table

550

Drug Therapy for Hypercholesterolemia in Patients With Cardiovascular Disease: Factors Limiting Achievement of Lipid Goals

551

Drug Therapy for Hypercholesterolemia: Time to End the Double Standard

552

Drug therapy for inflammatory bowel disease in pregnancy and the puerperium

553

Drug therapy for management of obesity

554

Drug therapy for management of obesity

555

Drug Therapy for Small Abdominal Aortic Aneurysm

556

Drug therapy for treatment of obesity

557

Drug therapy for urinary incontinence

558

Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy

559

Drug Therapy in Atrial Fibrillation Management: Where Do We Stand in 2010?

560

Drug therapy in paediatric patients

561

Drug therapy in reproductive endocrinology

562

Drug therapy increases long-term survival in pulmonary hypertension patients

563

Drug therapy of diabetes in the elderly

564

Drug therapy versus implantation of a cardiac defibrillator for the treatment of malignant arrhythmias in left ventricular dysfunction

565

Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism

566

Drug Trafficking and Criminal Justice

567

Drug trajectories among youth undergoing treatment: The influence of psychological problems and delinquency

568

Drug transfer through mucus

569

Drug transfer through mucus

570

Drug transport in corneal epithelium and blood–retina barrier: Emerging role of transporters in ocular pharmacokinetics

571

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines

572

Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels

573

Drug transport proteins in the liver

574

Drug treatment behind bars: Prison-based strategies for change : By Kevin E. Early Praeger Publishers (P.O. Box 5007, Westport, Connecticut 06881-5007), 1996, 192 pp., hardcover—$55.00

575

Drug treatment for bleeding oesophageal varices

576

Drug treatment for Crohnʹs disease

577

Drug treatment of bothersome lower urinary tract symptoms after ureteric JJ-stent insertion: A contemporary, comparative, prospective, randomised placebo-controlled study, single-centre experience

578

Drug treatment of delirium: Past, present and future

579

Drug treatment of non-variceal upper gastrointestinal bleeding

580

Drug treatment of obesity

581

Drug Treatment of Patients with Liver Cirrhosis in a Tertiary Hospital in Northern Ghana: Does It Comply with Recommended Guidelines?

582

Drug treatment outcome methodology (1993–1997): Strengths, weaknesses, and a comparison to the alcohol field

583

Drug treatment-related factors of inadequate seizure control

584

Drug treatments for obesity

585

Drug treatments for obesity

586

Drug treatments for obesity

587

Drug treatments for obesity – Authorsʹ reply

588

Drug treatments for obesity: orlistat, sibutramine, and rimonabant

589

Drug treatments of levodopa-induced dyskinesias

590

Drug Use among Residents of Juvenile Correctional Center in Kerman, Iran, and its Relationship with Personality Dimensions and Self-concept

591

Drug use and abuse in sport

592

Drug use and drinking among students in 36 countries

593

Drug Use and High-Risk Sexual Behaviors of Women at a Drop-In Center in Mazandaran Province, Iran, 2014

594

Drug use and HIV/ AIDS in Burma

595

Drug Use and Sex Work Among At-risk Women: A Qualitative Study of Initial Factors

596

Drug use and the severity of a traffic accident

597

Drug use behaviors among asian drug users in san francisco

598

Drug use behaviour of pregnant women in rural India

599

Drug use during pregnancy

600

Drug use during pregnancy

601

Drug use during pregnancy: are risk classifications more dangerous than the drugs?

602

Drug use evaluation of antibiotics prescribed in a Jordanian Hospital outpatient and emergency clinics using WHO prescribing indicators

603

Drug use evaluation of antibiotics prescribed in a Jordanian hospital outpatient and emergency clinics using WHO prescribing indicators

604

Drug Use Evaluation of Crystalline Penicillin in Pediatrics Ward of Dessie Referral Hospital, North East Ethiopia: A Hospital Based Cross Sectional Study

605

Drug Use Evaluation of Human Intravenous Immunoglobulin (IVIG) in a Teaching Hospital in East of Iran

606

Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study

607

Drug use is associated with elevated food consumption in college students

608

Drug Use Pattern Among Elderly People Referred to the Retirement Centers

609

Drug Use Patterns at Major Rock Concert Events

610

Drug usersʹ access to community-based services

611

Drug usersʹ brains to be removed 2 hours after death

612

Drug usersʹ sexual relationships and the social organisation of risk: The sexual relationship as a site of risk management

613

Drug utilisation and self-medication in rural communities in Vietnam

614

Drug utilization and nutrition patterns among children from indigent and emigrant families in Crete, Greece

615

Drug Utilization Evaluation of Agents Administered for Prevention and Treatment of Cancer-Related Infections

616

Drug Utilization Evaluation of Antibiotics in Burn Patients at a Referral Teaching Hospital

617

Drug Utilization Evaluation of Antibiotics in Intensive Care Units of a Referral Teaching Hospital

618

Drug Utilization Evaluation of Carbapenems in a Teaching Hospital in Tabriz-Iran

619

Drug Utilization Evaluation of Carbapenems in a Teaching Hospital in Tabriz-Iran

620

Drug Utilization Evaluation of Cefepime and Meropenem Based on the Infectious Disease Society of America and Defined Daily Dose Guidelines at the Payambare-Azam Bandar Abbas Hospital: A Retrospective Study

621

Drug Utilization Evaluation of Colistin: A Retrospective Study

622

Drug Utilization Evaluation of Imipenem and Intravenous Ciprofloxacin in a Teaching Hospital

623

Drug Utilization Evaluation of Imipenem in an Educational Hospital in Mazandaran Province

624

Drug Utilization Evaluation of Imipenem in Patients Undergoing Bone Marrow Transplantation

625

Drug utilization evaluation of meropenem: an important broad-spectrum antibiotic for the treatment of serious bacterial infections in hospitalized patients

626

Drug utilization evaluation of Rivaroxaban in both inpatient and outpatient settings: Using standard guidelines

627

Drug utilization evaluation of third generation cephalosporins using core drug use indicators

628

Drug Utilization Evaluation of Two Broad-Spectrum Antimicrobials: Cefepime and Piperacillin/Tazobactam in a Teaching Hospital in Tabriz, Iran

629

Drug Utilization Evaluation of Vancomycin in a Referral Infectious Center in Mazandaran Province

630

Drug Utilization Evaluation of Vancomycin in Pediatric Department

631

Drug utilization patterns in Rawalpindi and Islamabad, Pakistan

632

Drug Utilization Review of Conventional Amphotericin B in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplant Center

633

Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation Center

634

Drug Utilization Study on Acute Poisoning Cases Treated at a Tertiary Care Hospital in Western Part of India

635

Drug with potential to clear amyloid

636

Drug/device combinations for local drug therapies and infection prophylaxis

637

Drug-Coated Balloons for Infrapopliteal Disease: Digging Deep to Understand the Impact of a Negative Trial

638

Drug-company sponsorship and the Declaration of Helsinki

639

Drug-company sponsorship and the Declaration of Helsinki

640

Drug-delivering coronary artery stents: bare metal threatened by extinction?

641

Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal

642

Drug–DNA interaction: A theoretical study on the binding of thionine with DNAs of varying base composition

643

Drug–DNA interactions and their study by UV–Visible, fluorescence spectroscopies and cyclic voltametry

644

Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population

645

Drug-drug co-crystals

646

Drug-Drug Interaction Extraction via Convolutional Neural Networks

647

Drug–drug interaction mediated by inhibition and induction of P-glycoprotein

648

Drug-Drug Interactions among Kidney Transplant Recipients in The Outpatient Setting

649

Drug‐Drug Interactions in Elderly Adults in Dentistry Care: a Cross-Sectional Study

650

Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature

651

Drug-Drug Interactions: Influence of verapamil on the pharmacokinetics of sitagliptin in rats and Ex vivo models

652

Drug‑drug Interactions: The Importance of Medication Reconciliation (Letters to the Editor Volume 6 - Issue 1 - January-March 2017 )

653

Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin G

654

Drug-Drug/Drug-Excipient Compatibility Studies on Curcumin using Non-Thermal Methods

655

Drug-Drug-Induced Akathisia: Two Case Reports

656

Drug-efficacy depends on the inhibitor type and the target position in a metabolic network—A systematic study

657

Drug-eluted stent fracture occurred within 3 years lead to chronic total occlusion and aneurysm

658

Drug-eluting Balloon (DEB) for De-Novo Coronary Artery Disease and In-stent Restenosis: Immediate and Intermediate Term Results from a Prospective Registry

659

Drug-Eluting Balloon for Treatment of Superficial Femoral Artery In-Stent Restenosis

660

Drug-Eluting Balloon Versus Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in Critical Limb Ischemia: 12-Month Results From the IN.PACT DEEP Randomized Trial

661

Drug-eluting bioabsorbable stents – An in vitro study

662

Drug-Eluting Compared With Bare-Metal Coronary Stents Among Elderly Patients Original Research Article

663

Drug-eluting stent fracture occurred within 2 days after stent implantation

664

Drug-Eluting Stent Fracture within 6 Days after Stent Implantation

665

Drug-Eluting Stent Fracture: Promise and Performance

666

Drug-Eluting Stent Implantation and Coronary Collateral Growth Attenuation: Is Drug the Only Culprit?

667

Drug-Eluting Stent Implantation May Not Affect Vasomotor Function in Early Phase

668

Drug-Eluting Stent Restenosis: The Pattern Predicts the Outcome Original Research Article

669

Drug-Eluting Stent Thrombosis: A Pooled Analysis

670

Drug-Eluting Stent Thrombosis: A Pooled Analysis: Reply

671

Drug-Eluting Stent Thrombosis: Increasingly Recognized But Too Frequently Overemphasized

672

Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies Original Research Article

673

Drug-Eluting Stent Thrombosis: Results From the Multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos) Original Research Article

674

Drug-Eluting Stent-Induced Left Anterior Descending Coronary Artery Aneurysm: Repair by Pericardial Patch—Where Are We Headed?

675

Drug-Eluting Stent-Induced Vascular Dysfunction: Common and Missing Links

676

Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent I

677

Drug-Eluting Stenting for Unprotected Left Main Coronary Artery Disease: Are We Ready to Replace Bypass Surgery?

678

Drug-Eluting stents

679

Drug-Eluting Stents “Next Generation” Basic Science Workshop

680

Drug-eluting stents 1— preclinical

681

Drug-eluting stents 2-economics and cost effectiveness

682

Drug-eluting stents 3-restenosis following stenting with drug-eluting stents

683

Drug-eluting stents 4-paclitaxel, everolimus, and other agents

684

Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: Combination therapy for the future

685

Drug-Eluting Stents and Late Adverse Clinical Outcomes: Lessons Learned, Lessons Awaited

686

Drug-eluting stents and late stent thrombosis

687

Drug-Eluting Stents and the Future of Coronary Artery Bypass Surgery: Facts and Fiction

688

Drug-Eluting Stents Are Safe and Effective: Right or Wrong?

689

Drug-Eluting Stents for Acute Myocardial Infarction

690

Drug-eluting stents for coronary artery disease: A review

691

Drug-Eluting Stents for Critical Limb Ischemia

692

Drug-eluting stents for diabetes mellitus: A rush to judgment? Review Article

693

Drug-Eluting Stents for Saphenous Vein Graft Lesions: The Limits of Evidence

694

Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents

695

Drug-eluting stents in diabetics & Complex patient groups

696

Drug-Eluting Stents in Heart Transplant Recipients

697

Drug-Eluting Stents in the Treatment of Intermediate Lesions: Pooled Analysis From Four Randomized Trials Original Research Article

698

Drug-eluting stents in total coronary occlusions: Another piece of the puzzle solved?

699

Drug-eluting stents in vascular intervention

700

Drug-Eluting Stents Versus Bare Metal Stents for Narrowing in Saphenous Vein Grafts

701

Drug-Eluting Stents Versus Bare Metal Stents in Percutaneous Coronary Interventions (A Meta-Analysis)

702

Drug-Eluting Stents Versus Bilateral Internal Thoracic Grafting for Multivessel Coronary Disease

703

Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus

704

Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels

705

Drug-eluting stents, 5-sirolimus stents and oral rapamycin

706

Drug-eluting stents: A multidisciplinary success story

707

Drug-eluting stents: an innovative multidisciplinary drug delivery platform

708

Drug-eluting stents: Beyond the hyperbole

709

Drug-eluting stents: Factors governing local pharmacokinetics

710

Drug-eluting stents: Failures and restenosis

711

Drug-eluting stents: insights into safety and indications

712

Drug-eluting stents: is new necessarily better?

713

Drug-Eluting Stents: Is Their Future as Bright as Their Past?

714

Drug-eluting stents: Lesion subsets

715

Drug-Eluting Stents: Life Insurance With a Better Death Benefit

716

Drug-eluting stents: Miscellaneous

717

Drug-eluting stents: Patient and lesion subsets

718

Drug-eluting stents: Registries and trials

719

Drug-eluting stents: Registries and trials

720

Drug-eluting stents: results, promises and problems

721

Drug-eluting stents: some bare facts

722

Drug-Eluting Versus Bare Metal Stents for Saphenous Vein Graft Intervention

723

Drug-evaluation harmonisation will lead to fewer animal tests

724

Drug-exposed infant cases in juvenile court: risk factors and court outcomes

725

Drug-Facilitated Effects on Protective Airway Reflexes During Out-of-Hospital Endotracheal Intubation

726

Drug-free in vitro activation and autologous transplantation in infertile women with diminished ovarian reserve: An experimental pilot study

727

Drugging Drug Resistance

728

Drugging the Bad “AKT-TOR” to Overcome TKI-Resistant Lung Cancer

729

Drugging the Undruggable

730

Drug–GSH interaction on GSH–Au modified electrodes: A cyclic voltammetry and electrochemical impedance spectroscopy study

731

Drug-hormone interactions on neurobehavioral responses in human neonates

732

Drug-induced Acute Interstitial Nephritis Pathology, Pathogenesis, and Treatment

733

Drug-induced amnesia impairs implicit relational memory

734

Drug-induced and toxic myopathies

735

Drug-Induced Apnea in Children Admitted to Loghman Hakim Hospital, Tehran, Iran

736

Drug-induced atrial fibrillation Review Article

737

Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug Original Research Article

738

Drug-induced autoimmunity

739

Drug-Induced Brugada Syndrome in Children: Clinical Features, Device-Based Management, and Long-Term Follow-Up

740

Drug-Induced Bullous Pemphigoid: Rapid Resolution with Corticosteroid Therapy

741

Drug-Induced by Systemic Lupus Erythematosus Presenting as Recurrent Pericardial Effusion After Mitral Valve Repair

742

Drug-induced cholestasis

743

Drug-induced gingival overgrowth and its tentative pharmacotherapy

744

Drug-Induced Gingival Overgrowth in an 8-Year-Old Girl: A Case Report

745

Drug-induced headaches

746

Drug-induced headaches

747

Drug-induced heart failure

748

drug-induced hemophagocytosis

749

Drug-induced hepatocellular liver injury due to benzylpenicillin with evidence of lymphocyte sensitization

750

Drug-induced hyperkalemia

751

Drug-induced hyperkalemia: old culprits and new offenders

752

Drug-induced hyperkalemia: The reply:

753

Drug-Induced Hypersensitivity Syndrome (DRESS) by Phenobarbital - Case Report and Literature Review

754

Drug-Induced Hypersensitivity Syndrome Caused by Carbamazepine Used for the Treatment of Trigeminal Neuralgia

755

Drug-induced interstitial nephritis in a child with idiopathic nephrotic syndrome

756

Drug-Induced Lichen Planus

757

Drug-Induced Linear Immunoglobulin-A Bullous Dermatosis

758

Drug-induced liver diseases

759

Drug-induced liver injury following positive drug rechallenge

760

Drug-Induced Long QT Syndrome and Exome Sequencing: Chinese Shadows Link Past and Future

761

Drug-Induced Lupus Erythematosus

762

Drug-induced lupus erythematosus

763

Drug-induced methemoglobinemia during thoracoscopic lung biopsy

764

Drug-induced myocardial infarction in young patients: Report of two cases

765

Drug-induced Nephrotoxicity and Medicinal Plants

766

Drug-induced neurological disorders : by K.K. Jain, 1996, Hogrefe & Huber Publishers, Seattle, USA, 389 pages, US$ 79, ISBN 0-88937-154-7

767

Drug-Induced Pemphigoid:: Bullous and Cicatricial

768

Drug-Induced Pemphigus

769

Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine

770

Drug-Induced QT Interval Prolongation and Torsade De Pointes:Identification of Risk Factors

771

Drug-induced renal disorders

772

Drug-Induced Scleroderma and Sclerodermiform Conditions

773

Drug-induced stabilisation of a mismatched C-T base pair in a DNA hairpin

774

Drug-induced systemic lupus erythematosus and TNF-α blockers

775

Drug-induced systemic lupus erythematosus and TNF-α blockers

776

Drug-induced systemic lupus erythematosus and TNF-α blockers

777

Drug-induced systemic lupus erythematosus associated with etanercept therapy

778

Drug-induced torsades de pointes in one patient with congenital long QT syndrome

779

Drug-Induced Toxic Epidermal Necrolysis

780

Drug-induced tremors

781

DRUG-INDUCED VASCULITIS IN A BREAST CANCER PATIENT RECEIVING CHEMOTHERAPY

782

Drug–lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces

783

Drug-licensing anomalies and Parkinsonʹs disease

784

Drug-loaded chondroitin sulfate-based nanogels: Preparation and characterization

785

Drug-loaded electrospun nanofibrous sheets as barriers against postsurgical adhesions in mice model

786

Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells

787

Drug-lunch alert

788

Drugmaker seeks permissions to collaborate on Cuban vaccine

789

Drug–protein interactions assessed by fluorescence measurements in the real complexes and in model dyads

790

Drug-related Death low Registration in Iran: A Mixed Method Approach for Causes, Recommendations to Solve This Problem and Geographical Evaluation of an Intervention

791

Drug-related deaths by region, sex, and age group per 100 injecting drug users in Scotland, 2000–01

792

Drug-related killings: a case of mistaken identity Review Article

793

Drug-related problems (DRPs) identified from geriatric medication safety review clinics

794

Drug-related Problems Among Type 2 Diabetic Patients With Hypertension in a Tertiary Care Hospital in Lebanon: A Cross-sectional Study

795

Drug‑related Problems in Hypertensive Patients: A Cross‑sectional Study from Indonesia

796

Drug-related Problems in Solid-Organ Transplant Recipients Hospitalized for COVID-19: An Experience of a Referral Tertiary Center in Iran

797

Drug-Resistance Associated Mutations in Polymerase (P) Gene of Hepatitis B Virus Isolated From Malaysian HBV Carriers

798

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

799

Drug-resistant enteric fever in the UK

800

Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome

801

Drug-resistant genotyping in HIV-1 therapy

802

Drug-resistant genotyping in HIV-1 therapy

803

Drug-resistant genotyping in HIV-1 therapy

804

Drug-resistant genotyping in HIV-1 therapy

805

Drug-resistant genotyping in HIV-1 therapy

806

Drug-resistant gonorrhoeae spread in the USA

807

Drug-Resistant Phosphatidylinositol 3-Kinase: Guidance for the Preemptive Strike

808

Drug-resistant Pneumocystis carinii

809

Drug-Resistant Proteus Virulence Factors Characterization and Their Inhibition Using Probiotic Bacteria

810

Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome

811

Drug-resistant strains of HIV increase sharply in Japan

812

Drug-resistant Streptococcus pneumoniae: rational antibiotic choices

813

Drug-resistant tuberculosis

814

Drug-Resistant Tuberculosis and Group 5 Anti-Tuberculosis Drugs

815

Drug-resistant tuberculosis in Taipei, 1996-1999

816

Drug-resistant tuberculosis: desperate measures?

817

Drugs & devices in brief

818

Drugs against superbugs: private lessons from bacteriophages

819

Drugs and a dark future

820

Drugs and Addictive Behaviour: A Guide to Treatment (3rd edition): Hamid Ghodse, Cambridge University Press 2002. £39.95, 520 pages

821

Drugs and demons

822

Drugs and mental health

823

Drugs and narcotics in history : Edited by Roy Porter and Mikulas Teich. Cambridge University Press, Cambridge, 1995. xii + 227 pp., U.S.$49.95 (cloth)

824

Drugs and nutrition: how side effects can influence nutritional intake

825

Drugs and nutrition: Important drug-nutrient interactions

826

Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea

827

Drugs and pests: intertemporal production externalities

828

Drugs and Pharmacology for Nurses, 12th edn, S.J. Hopkins. Churchill Livingstone (1995), ISBN: 0-443-05249-2

829

Drugs and risk-taking in tourism

830

Drugs and the art of Fred Tomaselli

831

Drugs and the immune system: the emerging era of immunopharmacology

832

Drugs deaths drop in Switzerland

833

Drugs elevating extracellular adenosine enhance cell cycling of hematopoietic progenitor cells as inferred from the cytotoxic effects of 5-fluorouracil

834

Drugs Expiration Date Dilemma!

835

Drugs for Left Ventricular Remodeling in Heart Failure

836

Drugs for obstetric conditions

837

Drugs for the gynecologist to prescribe in the prevention of breast cancer: Current status and future trends

838

Drugs for vascular dementia

839

Drugs in Exacerbation and Provocation of Psoriasis

840

Drugs in Nursing Practice: C R Henney, RJ Dow, A M Macconnachie Churchill Livingstone, 1995, 5th edn ISBN 0-443-05235-2, 482 pages Price £12.95

841

Drugs in Pregnancy and Lactation, Sixth Edition: Gerald G. Briggs, Roger K. Freeman, & Sumner J.Yaffe. ISBN 0-7817-3203-4, Lippincott Williams & Wilkins, Philadelphia, 2002, 1595 pp

842

Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources – a review

843

Drugs in the Plant

844

Drugs in the postgenomic era

845

Drugs Induced Alzheimer’s Disease in Animal Model

846

Drugs lose out to revascularisation in symptom-free coronary disease

847

DRUGS MINIMIZING BLOOD LOSS DURING LIVER TRANSPLANTATION

848

Drugs of Abuse and Alcohol in Weekend Drivers Involved in Car Crashes in Belgium, , ,

849

Drugs of Abuse and Immuno-Modulation

850

Drugs of abuse and reward comparison: a brief review

851

Drugs of abuse and the elicitation of human aggressive behavior

852

Drugs of abuse in oral fluid collected by two different sample kits – Stability testing and validation using ultra performance tandem mass spectrometry analysis

853

Drugs of abuse in pregnancy

854

Drugs of abuse in urban groundwater. A case study: Barcelona Original Research Article

855

Drugs or Implantable Cardioverter-Defibrillators in Patients with Poor Left Ventricular Function?

856

Drugs Prescribed by Dentists in Fars Province, Iran

857

Drugs solubilization in ascorbyl–decanoate micellar solutions

858

859

Drugs Used in Pregnancy

860

Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action

861

Drugs, diet and disease

862

Drugs, HIV Treatment and Harm Reduction Services for Afghan Refugees in Iran

863

Drugs, leads, and drug-likeness: an analysis of some recently launched drugs

864

DRUGS-FACILITATED STREET AND TRAVEL RELATED CRIMES: A NEW PUBLIC HEALTH ISSUE

865

Drug-testing practices in US hotels

866

Drug-trial “irregularities” uncovered in Argentina

867

Drug-trial compensation demands in lreland

868

Drug-use behavior and correlates in people with schizophrenia

869

Drug-use initiation and conduct disorder among adolescents in drug treatment

870

Druid wins Baan contract with Weston Aerospace

871

Drum agglomeration behavior of nickel laterite ore: Effect of process variables

872

Drum granulation of NPK fertilizers

873

Drum leaching tests in iron removal from quartz using oxalic and sulphuric acids

874

Drum Sound Recognition for Polyphonic Audio Signals by Adaptation and Matching of Spectrogram Templates With Harmonic Structure Suppression

875

Drum-boiler dynamics

876

Drum-like silencers using magnetic forces in a pressurized cavity

877

878

Drunk drivers in the courts: Legal and extra-legal factors affecting pleas and sentences

879

Drunk driving and mental disorders

880

Drunk driving and mental disorders

881

Drunk, but not blind: The effects of alcohol intoxication on change blindness

882

Drupangtonine, a novel antileukemic alkaloid from Cephalotaxus harringtonia var. drupacea

883

Drushbametrics — My Russian adventures

884

Dry aging of beef in a bag highly permeable to water vapour

885

Dry air effects on the copper oxides sensitive layers formation for ethanol vapor detection

886

Dry anaerobic digestion of food waste under mesophilic conditions: Performance and methanogenic community analysis

887

Dry and lubricated wear resistance of mechanically-alloyed aluminium-base sintered composites

888

Dry and semi-dry machining using finely crystallized diamond coating cutting tools

889

Dry and Wet Abrasive Conditions of Fe-C-B Wear Resistance Hardfacing Alloy on Mild Steel

890

Dry and wet abrasive resistance of Inconel 600 and stellite

891

Dry and wet atmospheric deposition of nitrogen and phosphorus in Singapore

892

Dry and wet deposition of elemental carbon on a tropical forest in Thailand

893

Dry and wet deposition of elements in Hong Kong

894

Dry and wet deposition of mercury near a chlor-alkali plant

895

Dry and wet deposition of nutrients from the tropical Atlantic atmosphere: Links to primary productivity and nitrogen fixation

896

Dry and wet deposition of water-insoluble dust and water-soluble chemical species during spring 2007 in Tsukuba, Japan

897

Dry and wet rainy seasons in the Mantaro river basin (Central Peruvian Andes)

898

Dry and wet sliding wear of ITO-coated PET components used in flexible optoelectronic applications

899

Dry and Wet Wear Characteristic of TiO2 Thin Film Prepared by Magnetic Sputtering in Ringer Solution

900

Dry ashing of organic rich matrices with palladium for the determination of arsenic using inductively coupled plasma-mass spectrometry Original Research Article

901

Dry atmospheric deposition and deposition velocities of dicamba, 2,4-dichlorophenoxyacetic acid and γ-1,2,3,4,5,6-hexachlorocyclohexane Original Research Article

902

Dry atmospheric deposition and diazotrophy as sources of new nitrogen to northwestern Mediterranean oligotrophic surface waters

903

Dry atmospheric deposition rates of metals along a coastal transect in southern California

904

Dry atmospheric fluxes of trace metals (Al, Fe, Mn, Pb, Cd, Zn, Cu) over the Levantine Basin: A refined assessment

905

Dry atmospheric inputs of trace metals at the Mediterranean coast of Israel (SE Mediterranean): sources and fluxes

906

Dry bag isostatic pressing for improved green strength of surrogate nuclear fuel pellets

907

Dry Bean Intake of Women Ages 19-45

908

Dry Bean Production in Zero and Conventional Tillage

909

Dry beneficiation of Slovakian coal

910

Dry beneficiation technology of coal with an air dense-medium fluidized bed

911

Dry boards as load bearing element in the profiled steel sheet dry board floor panel system—structural performance and applications

912

Dry catalyst impregnation in a double cone blender: A computational and experimental analysis

913

Dry catalytic partial oxidation of diesel–fuel distillates into syngas

914

Dry citrate-precursor synthesized nanocrystalline cobalt oxide as highly active catalyst for total oxidation of propane

915

Dry cleaning for metallic contaminants removal as the second cleaning process after the CMP process

916

Dry cleaning of metal surfaces by a vacuum arc

917

Dry climate near the Western Pacific Warm Pool: Pleistocene caliches of the Nansha Islands, South China Sea

918

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

919

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

920

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

921

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

922

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

923

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

924

Dry coating of talc particles with fumed silica: Influence of the silica concentration on the wettability and dispersibility of the composite particles

925

Dry coating polymer powder particles with deagglomerated carbon nanotubes to improve their dispersion in nanocomposites

926

Dry coatings and ecodesign part. 1 — Environmental performances and chemical properties

927

Dry coatings and ecodesign: Part. 2 — Tribological performances

928

Dry cooling towers as condensers for geothermal power plants

929

Dry cooling with night cool storage to enhance solar power plants performance in extreme conditions areas

930

Dry cupping therapy and the wellness management of health travelers

931

Dry cutting performance of partially filtered arc deposited titanium aluminium nitride coatings with various metal nitride base coatings

932

Dry deep drawability of A5052 aluminum alloy sheet with DLC-coating

933

Dry degumming of vegetable oils by membrane filtration Original Research Article

934

Dry dense medium separation of iron ore using a gas–solid fluidized bed

935

Dry densification of carbon nanotube bundles Original Research Article

936

Dry deposition (downward, upward) concentration study of particulates and heavy metals during daytime, nighttime period at the traffic sampling site of Sha-Lu, Taiwan

937

Dry deposition and concentration of marine aerosols in a coastal area, SW Sweden

938

Dry deposition and foliar leaching of mercury and selected trace elements in deciduous forest throughfall

939

Dry deposition and interception of 4–22 μm diameter particles to a lettuce crop

940

Dry deposition and internal circulation of nitrogen, sulphur and base cations to a coniferous forest

941

Dry deposition and particle-size distribution of phosphorus in the marine atmosphere over the northeastern coast of Taiwan

942

Dry deposition and particle-size distributions of polycyclic aromatic hydrocarbons in the ambient air of a petrochemical plant

943

Dry deposition and resuspension of particle-associated metals near a freeway in Los Angeles

944

Dry deposition and soil–air gas exchange of polychlorinated biphenyls (PCBs) in an industrial area

945

Dry deposition calculations for the clean air status and trends network

946

Dry deposition effect of marine aerosol to the building stone of the medieval city of Rhodes, Greece

947

Dry deposition fluxes and atmospheric size distributions of mass, al, and mg measured in southern Lake Michigan during aeolos

948

Dry deposition fluxes and deposition velocities of PAHs at an urban site in Turkey

949

Dry deposition fluxes and velocities of polychlorinated biphenyls (PCBs) associated with particles

950

Dry deposition fluxes of ambient particulate heavy metals in a small city, Korea

951

Dry deposition measured with a water surface sampler: a comparison to modeled results

952

Dry deposition model for atmospheric particles

953

Dry deposition modelling of atmospheric aerosols from a lead smelting industry

954

Dry deposition of 214Pb to conifers

955

Dry deposition of acidic air pollutants to tree leaves, determined by a modified leaf-washing technique

956

Dry deposition of aerosol particles within model spruce canopies

957

Dry deposition of ammonia, nitric acid, ammonium, and nitrate to alpine tundra at Niwot Ridge, Colorado

958

Dry deposition of atmospheric polycyclic aromatic hydrocarbons (PAHs) in the southeast suburb of Beijing, China

959

Dry deposition of electrically charged aerosols

960

Dry deposition of gaseous elemental mercury to plants and soils using mercury stable isotopes in a controlled environment

961

Dry deposition of gaseous oxidized mercury in Western Maryland Original Research Article

962

Dry deposition of gaseous radioiodine and particulate radiocaesium onto leafy vegetables Original Research Article

963

Dry deposition of large, airborne particles onto a surrogate surface

964

Dry Deposition of Nonspherical Particles on Natural and Surrogate Surfaces

965

Dry deposition of ozone on building materials. Chamber measurements and modelling of the time-dependent deposition

966

Dry deposition of particles and canopy exchange: Comparison of wet, bulk and throughfall deposition at five forest sites in Italy

967

Dry deposition of particles in a coastal forest

968

Dry deposition of particles to building surfaces and soiling

969

Dry deposition of particles to wave surfaces: I. Mathematical modeling

970

Dry deposition of particles to wave surfaces: II. Wind tunnel experiments

971

Dry deposition of polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) in ambient air

972

Dry deposition of polycyclic aromatic hydrocarbons in urban and rural sites of Western Greece

973

Dry deposition of reactive nitrogen to marine environments: recent advances and remaining uncertainties

974

Dry Deposition of SO2 Over Dry Dipterocarp Forest, Thailand

975

Dry deposition of sulfate-containing particulate at the highway intersection, coastal and suburban areas

976

Dry deposition of sulphate and nitrate to polypropylene surfaces in a semi-arid area of India

977

Dry deposition of sulphur dioxide and ammonia on wet surfaces and the surface oxidation kinetics of bisulphite

978

Dry deposition of sulphur over eastern South Africa

979

Dry deposition profile of small particles within a model spruce canopy

980

Dry deposition to forests—On the use of data from clearings

981

Dry deposition to pine of sulphur dioxide and ozone at low concentration

982

Dry deposition velocity of PM2.5 ammonium sulfate particles to a Norway spruce forest on the basis of S- and N-balance estimations

983

Dry deposition velocity of sulfur dioxide over rice paddy in the tropical region

984

Dry deposition washoff and dew on the surfaces of pine foliage on the urban- and mountain-facing sides of Mt. Gokurakuji, western Japan

985

Dry deposition, concentration and gas/particle partitioning of atmospheric carbazole

986

Dry deposition, ionic species measured and source interpretation during seasonal cycle at offshore areas near Taiwan Strait

987

Dry deposition, seasonal variation and source interpretation of ionic species at Abali, Firouzkouh and Varamin, Tehran Province, Iran

988

Dry dilute acid pretreatment by co-currently feeding of corn stover feedstock and dilute acid solution without impregnation

989

Dry dispersion of fine particles in gaseous phase

990

Dry dispersion of plant pulp in concrete and use thereof

991

Dry drainage: A sustainable solution to waterlogging and salinity problems in irrigation areas?

992

Dry elasto-plastic contact of nominally flat surfaces

993

Dry electrical discharge machining of cemented carbide

994

Dry etch characteristics of Al-Nd films for TFT-LCD

995

Dry etch chemistries for TiO2 thin films

996

Dry etching and implantation characteristics of III-N alloys

997

Dry etching and implantation characteristics of III-N alloys

998

Dry etching characteristics and surface reconstruction of Cl/Si(1 1 3)

999

Dry etching characteristics of (Ba0.6,Sr0.4)TiO3 thin films in high density CF4/Ar plasma

1000

Dry etching characteristics of GaN for blue/green light-emitting diode fabrication

بازگشت